NCT06700057View on ClinicalTrials.gov

Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2027

Conditions
Prostate CancerMetastasis
Trial Locations (1)

33600

RECRUITING

Institut Bergonie, Bordeaux

Sponsors

Lead Sponsor

Institut Bergonié
All Listed Sponsors
lead

Institut Bergonié

OTHER